Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout. | | | 10 - 50 | 2025 | $205,000,000 |
World Class Health is a Hospitals and Health Care company. | New York | NY | 1 - 10 | 2024 | |
Lift Labs is a creator of a suite of home health hardware for people living with Parkinson's Disease and Essential Tremor. Its core R&D focuses on areas of healthcare, sustainability, safety, and education. The company was founded in 2010 and is headquartered in San Francisco, California. | San Francisco | CA | 5 - 10 | 2024 | $2,900,000 |
Zarminali Health is a medical organization. | Chicago | IL | 20 - 50 | 2024 | $150,000,000 |
Jupiter Endovascular is a medical technology start-up. Its mission is to cover the entire spectrum of cardiovascular illness, seeing compelling potential to reinvent treatments for millions of people. | Menlo Park | CA | 10 - 50 | 2024 | $21,000,000 |
KALM Therapeutics provides non-steroidical treatment for eczema and psoriasis. | Huntsville | AL | 2 - 10 | 2024 | $590,380 |
Responsive Arthroscopy is a medtech company that offers medical devices for the sports medicine field. | | | 10 - 50 | 2024 | $9,999,999 |
Coeptis Therapeutics focuses on the development and acquisition of pharmaceutical products. Coeptis’ pipeline is evolving from the partnerships being created with multiple pharmaceutical companies currently. As these relationships unfold, the product pipeline will be updated accordingly. | Wexford | PA | 5 | 2024 | $25,192,500 |
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders. | Boulder | CO | 20 - 50 | 2024 | $41,000,000 |
Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies. | | | 10 - 50 | 2024 | $105,000,000 |
Developing innovative therapeutics to materially improve the lives of patients. We strive to be transparent and open in our goals, plans, and progress. | San Diego | CA | 20 - 50 | 2024 | $370,000,000 |
Seaport Therapeutics operates as a clinical stage biopharmaceutical company. | Boston | MA | 20 - 100 | 2024 | $340,000,000 |
City Therapeutics is a biopharmaceutical company focusing on engineering next-generation small-interfering RNAs (siRNAs) to enhance RNAi-based therapies. The company develops a pipeline of innovative RNAi therapeutics aimed at addressing various disease indications. City Therapeutics prioritizes improving and expanding RNAi technology to achieve better patient outcomes. The leadership team includes experienced scientists and industry professionals dedicated to advancing the field of RNA interference. | Cambridge | MA | 10 - 50 | 2024 | $234,500,000 |
Mirador Therapeutics envisions precision medicine for immune-mediated inflammatory and fibrotic diseases. | San Diego | CA | 20 - 50 | 2024 | $480,000,000 |
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications. | Waltham | MA | 4 | 2024 | $797,600,000 |
NuvoMed offers a patented, disposable device called the DisImpactorTM, developed for the safe, fast, and effective relief of fecal impaction with maximum comfort and clinical efficacy. The company is committed to improving this unpleasant procedure for both the patient and physician. By significantly reducing the pain for the patient while providing a more capable tool for the physician, NuvoMed intends to provide the ultimate solution. The company was founded in 2012 and is based in Seattle, Washington. | Seattle | WA | 2 - 10 | 2023 | $1,425,653 |
Lynch Regenerative Medicine is a healthcare company. | Franklin | TN | 10 - 50 | 2023 | $3,750,000 |
LunOSA is developing a self-expanding, injectable neurostimulator to treat obstructive sleep apnea, unlocking a $10B market limited currently by procedures that require face surgery | Somerville | MA | 1 - 10 | 2023 | $15,000,000 |
Optain is a manufacturer of medical equipment and software. Optain is to make healthcare available to all people so that all can live healthy lives. Optain uses AI to create affordable clinical assistance solutions that make illness screening simple, anytime, and anywhere. | New York | NY | 10 - 50 | 2023 | $38,000,000 |
Granza Bio is a company that developing cancer therapies based on human body's immune system. | San Francisco | CA | 2 - 10 | 2023 | $7,640,000 |
Maia Oncology is an onco-primary care clinic for cancer patients and survivors. | New York | NY | 2 - 10 | 2023 | $4,250,000 |
Anaphero is health care unit that helps in reducing clinical staff shortage using virtual agents that can safely interact with patients. | | | 2 - 10 | 2023 | |
Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies . | Los Angeles | CA | 5 - 20 | 2023 | $30,000,000 |
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease. | San Francisco | CA | 87 | 2023 | $1,324,000,000 |
Axena Health is a women-led company dedicated to improving the lives of women with pelvic floor disorders by leveraging the power of digital technology. | Auburndale | MA | 20 - 50 | 2023 | $38,000,000 |
Balance Ophthalmics is a healthcare company that offers opthalmology related services. | Sioux Falls | SD | 2 - 10 | 2023 | $5,749,964 |
Shasta Health is a physical therapy center that offers patient acquisition, billing, care plans, and other care facilities. | San Francisco | CA | 2 - 10 | 2023 | $500,000 |
Switchboard Health helps payers, health systems, employers, and at-risk providers leverage virtual care solutions at scale. With our innovative technology and services, we activate people who need care, match them to the right provider, track the quality of their care, and support them across their entire care journey. | Boise | ID | 5 - 20 | 2023 | $8,749,999 |
Long Description: Aiolos Bio is a biotech company focused on developing therapies for respiratory diseases like asthma as well as other immune conditions. The company is initially focused on advancing AIO-001, a monoclonal antibody therapy for moderate-to-severe asthma that only requires dosing every 6 months. Aiolos Bio was founded by an accomplished team with decades of drug development experience and leadership in the biotech industry. | San Francisco | CA | 20 - 50 | 2023 | $245,000,000 |
Pario Health's mission is to make patient-centric care for independent women's health practitioners a reality again by radically simplifying clinical documentation, practice management, and billing with one integrated platform. Through integrated ordering, streamlined charting customized for women's healthcare, and artificial intelligence, we are eliminating the redundant workflows and poor user experience to bring practices a modern, delightful EMR experience that optimizes for improved outcomes and profitability.
Why use a hundred clicks when one will do?
Powerful functionality. Radical Simplicity. Welcome to Pario. | New York | NY | 2 - 10 | 2023 | $4,000,000 |
Mach5 Therapeutics is a biotechnology company. | Atlanta | GA | 1 - 10 | 2023 | $23,354,509 |
We are Montara Therapeutics, a San Francisco-based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory Board (SAB).
We bring a new approach to tackling challenging established targets, along with unique experience in developing enzyme activators and domain expertise in mitophagy.
Our mission is to create innovative therapies for diseases of the CNS, with a focus on precision medicine and genetically validated targets to enhance drug safety and efficacy. | San Francisco | CA | 20 - 50 | 2023 | $31,300,000 |
Exthymic is a medical organization currently based in San Diego, California, United States. It has been founded in 2023. | | | 1 - 10 | 2023 | $10,249,992 |
Midstream Health is a healthcare company. | | | 1 - 10 | 2023 | $6,684,998 |
Primrose Bio is a biotech company that focuses on discovery, development, and manufacturing of new molecules. innovative therapeutics, vaccines and ingredients to aevance global health. | San Diego | CA | 50 - 100 | 2023 | $16,489,924 |
Insighta, a landmark Joint Venture between Prenetics (NASDAQ: PRE), and renowned scientist, Prof. Dennis Lo, aims to revolutionize multi-cancer early detection. Backed by world-class science from Prof. Lo, robust capital resources of US$100m from Prenetics, and led by successful entrepreneur Danny Yeung, the joint venture is poised to transform cancer screening. Insighta plans to introduce Presight for lung and liver cancers in 2025, and to expand with Presight One for 10+ cancers in 2027. Insighta presents an unprecedented opportunity to save lives and bolster Hong Kong's standing as a global hub for life sciences innovation. | | RI | 10 - 50 | 2023 | $30,000,000 |
Kardigan is a patient-driven heart health firm that is revolutionizing cardiovascular drug development to produce medicines that take patients from symptom management to functional cures. | South San Francisco | CA | 10 - 200 | 2023 | $554,000,000 |
Architect Therapeutics is a developer of therapeutics that focuses on creating treatments for diseases, particularly in the field of cancer. | | | 5 - 10 | 2023 | |
We build and operate in-house pharmacies for safety net clinics, with a focus on STD clinics, Ryan Whites, and FQHCs serving patients living with HIV and Hepatitis C. We provide the entire physical, clinical, and digital infrastructure needed to operate and grow best-in-class 340B pharmacy programs.
Our team has deep clinical pharmacy, technology, and operations experience. Together, we have spent 18 years in Africa building the largest HIV access program in the world, and we have set up, operated and scaled pharmacies that have dispensed over 25M+ prescriptions to patients across all 50 states in the US. After setting up your in-house pharmacy, we design and implement clinical pharmacy programs and deploy technology products that leverage your pharmacy to expand patient reach, improve clinical outcomes, and increase the financial impact of your 340B program.
We are on a mission to serve safety net clinics and their patients. Drop us a line at hello@alchemyhealth.com. | San Francisco | CA | 20 - 50 | 2023 | $31,000,000 |
Tandem Health focuses on providing care, whereas Tandem allows you to conveniently make medical notes immediately following the patient session. Tandem Health creates technologies that simplify administration in healthcare. | | | 20 - 100 | 2023 | |
Andromeda Surgical is a developer of autonomous robots intended to make surgery more consistent, error-free, and efficient. | San Francisco | CA | 5 - 20 | 2023 | |
Clearwave operates a healthcare network that allows medical facilities to authenticate insurance eligibility of patients. | | | 10 - 200 | 2023 | $5,295,884 |
Medical Innovation Centers of America is a healthcare billing company which utilizes AI technology for all aspects of billing. | Broken Arrow | OK | 10 - 50 | 2023 | $1,125,000 |
CrossBridge Bio operates as a biotechnology company, innovates ADC therapeutics through stable dual linker payload technology. | | | 5 - 10 | 2023 | $10,000,000 |
iVEAcare develops innovative neuromodulation therapy to treat unmet clinical needs. | Saint Paul | MN | 5 - 20 | 2023 | $27,500,000 |
Atraverse Medical offers a product development for left-heart access technology to simplify workflows and improve patient outcomes. | Chicago | IL | 20 - 50 | 2023 | $41,900,000 |
Attovia Therapeutics is a biotherapeutics pipeline developer focused on immune-mediated illness and oncology. The company uses the nanobody platform to create tiny format binders with low picomolar affinity, increased selectivity, quicker internalization, and rapid tissue penetration, thereby assisting cancer patients' treatment. | Fremont | CA | 20 - 50 | 2023 | $255,000,000 |
Stem Cell Implants is a biotech business that uses stem cell technology to transform dental and craniofacial prosthetic implants. Stem Cell Implants envisions a new regenerative medicine frontier in dentistry. | | | 1 - 10 | 2023 | |
Sealonix focuses on the development and commercialization of hemostatic sealants using its proprietary biomaterials. Sealonix is working on a sealant patch that will provide quick hemostasis for abdominopelvic and orthopedic operations. The PramStat patch is intended to bioabsorb within one week of implantation. | Bedford | MA | 2 - 10 | 2023 | $20,000,000 |
Tuesday Health empowers lives through supportive care by easing the symptoms and stress of serious illness. | Nashville | TN | 20 - 50 | 2023 | $60,000,000 |
Peregrine Health is a healthcare company formed by Integrative Life Network (ILN) and Integrative Health Centers. | Nashville | TN | 20 - 50 | 2023 | $13,514,671 |
Sylke is a healthcare products manufacturing company that offers silk fibroin adhesive wound closure. | | | 20 - 50 | 2023 | $15,531,995 |
Synaptrix is committed to offering free of drugs, lasting alternatives for postoperative pain treatment using NOVABLOC. | Alpharetta | GA | 2 - 10 | 2023 | $10,000,000 |
Advanced Medicine Partners is a biotechnology company that specializes in viral vector manufacturing for genes and cells. | Lake Forest | IL | 20 - 50 | 2023 | $32,000,000 |
MedsEngine is a software company currently based in Greene, Iowa, United States. It has been founded in 2023. | Greene | IA | 1 - 10 | 2023 | $5,795,454 |
Mozarc Medical leverages both companies’ leadership and expertise to develop transformative kidney health technologies. The company focuses on the development of innovative technologies that reshape kidney health with patient-centered solutions. | Minneapolis | MN | 1,000 - 5,000 | 2023 | $22,399,377 |
Selera Medical is developing a device-based treatment for heart failure, to treat fluid overload in heart failure patients with a one-time, minimally invasive procedure | Mountain View | CA | 2 - 10 | 2023 | $500,000 |
Uptiv Health provides human-centered care for people with complex needs within and beyond the four walls of a clinic setting. | Westland | MI | 5 - 20 | 2023 | $7,500,000 |
Amplifyer Bio is a biotechnology research company that develops technology of transformative potential for the liquid biopsy field. | Lexington | MA | 5 - 10 | 2023 | $7,078,494 |
Retension Pharmaceuticals is developing RTN-001, a differentiated, tissue-targeted PDE5 inhibitor that has been optimized for the treatment of uncontrolled hypertension. RTN-001 has been evaluated in over 265 subjects across 9 clinical trials. In these studies, RTN-001 was well tolerated and demonstrated a sustained and clinically significant impact on central and brachial blood pressure in patients with uncontrolled hypertension. RTN-001 is a second generation PDE5i that preferentially distributes to cardiovascular tissues, where it acts to mediate a sustained and clinically significant impact on central and brachial blood pressure in patients with uncontrolled hypertension. | Falls Church | VA | 2 - 10 | 2023 | $25,400,000 |
A forward-thinking company committed to responsibly integrating new technologies in the healthcare industry. | Southlake | TX | 10 - 50 | 2023 | $2,879,586 |
Halo Health Clinic is a healthcare center that offers diagnosis and treatment services for psychiatric and mental health wellness. | Las Vegas | NV | 10 - 50 | 2023 | $1,875,000 |
Avenacy is a rapidly growing U.S.-based specialty pharmaceutical company focused on providing critical injectable medications used to treat patients in various medically supervised settings, from acute care hospitals to outpatient clinics and physician offices. Through a rigorous and optimized selection process, the Company is building out a pipeline of high-quality FDA approved injectable products to ensure a resilient portfolio that can meet the needs of today’s dynamic drug supply chain. With an experienced team, commitment to quality and reliability, and product offerings intended to facilitate safe and efficient patient care, Avenacy strives to be a trusted partner for essential injectable medications. | Schaumburg | IL | 10 - 50 | 2023 | $26,030,368 |
Pantheon Vision is an ophthalmic medical device company in its early stages. | Baltimore | MD | 5 - 10 | 2023 | $4,300,000 |
Enabling women's health providers to start, grow, and operate their own practices. | Dover | DE | 2 - 10 | 2023 | $500,000 |
Habitat Health was founded in 2023 to deliver fully integrated health and social care to older adults on Medicare or Medicaid who wish to remain living independently in their homes and communities. The company operates its model through the Program of All-Inclusive Care for the Elderly ("PACE") in collaboration with local community partners. The company is supported by Kaiser Permanente, Town Hall Ventures, and New Enterprise Associates. | | | 20 - 50 | 2023 | $50,000,000 |
Silo Pharma, Inc. is a developmental stage biopharmaceutical company. The Company specializes in developing novel therapeutics that address underserved conditions including PTSD, stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. Silo Pharma operates in the United States. | Sarasota | FL | 3 | 2023 | $12,006,060 |
Brightstar Therapeutics is a biotechnology company focused on innovative treatment options that improve clinical outcomes and quality of life for people living with corneal and ocular surface diseases. | Lexington | KY | 5 - 10 | 2023 | |
Kenvue is a consumer health company that delivers personal health solutions. The company's brands have helped generations take care of themselves and their loved ones for more than 135 years. | Skillman | NJ | 22,000 | 2023 | $3,646,591,000 |
Author Health is a platform that provides comprehensive care and treatment for Medicare Advantage recipients with substance use disorders and severe mental illnesses. The company offers a team-based approach to care, grouping specialized physicians, therapists, nurses, and community health workers to give a mix of in-person and virtual care for patients who are often disconnected from the traditional healthcare system. Author Health launched from stealth in 2023 with $115 million in funding led by General Atlantic and Flare Capital Partners. | Boston | MA | 50 - 100 | 2023 | $115,000,000 |
SaaS for managing healthcare contracts and payments | New York | NY | 2 - 10 | 2023 | $3,000,000 |
In order to eliminate preventable death and disability from injury, trauma programs need more than a basic data repository. They need modern tools that help their entire teams do their best work. We are the most advanced trauma platform designed to help Surgeons, TPMs, Registrars, PI Coordinators and Injury Prevention Coordinators be their most effective selves. | Winter Park | FL | 10 - 50 | 2023 | $4,082,799 |
Arbital Health is a healthcare company that offers a third-party adjudication utility to help bolster outcomes-based healthcare contracts. | Santa Rosa | CA | 10 - 50 | 2023 | $41,000,000 |
Georgetown Surgery Center is a healthcare service providing company that specializes in surgical services. | Georgetown | TX | 10 - 50 | 2023 | $1,816,032 |
Accelerate Dental Holdings is a dental healthcare centre | Murray | UT | 10 - 50 | 2023 | $11,900,000 |
twenty30 health brings a technology-enabled, patient-first and coordinated, multimodal approach to delivery of obesity care. We deliver whole-person, evidence-based interventions, with a best-in-class provider network to drive sustained weight loss and metabolic health. | Philadelphia | PA | 10 - 50 | 2023 | $5,190,000 |
Parasail is the first AI Deployment Network built for the new era of open and scalable AI. They connect teams to the world’s largest pool of on-demand GPU compute—giving AI builders fast, flexible, and cost-efficient infrastructure to deploy and scale models without contracts, quotas, or cloud complexity. | | | 5 - 10 | 2023 | $42,000,000 |
Sohar Health is a platform for behavioral health companies. It is an API-based solution to handle eligibility verification, and AI-powered medical coding to automate manual workflows, increase patient intake, and generate more revenue | New York | NY | 1 - 10 | 2023 | $11,367,000 |
Envelope Money is an All-in-one banking and budgeting software that manages family finances. | San Francisco | CA | 5 - 10 | 2022 | $700,000 |
Morf Health is making it 10x faster for healthcare providers to setup and maintain integrations across their tech stack, e.g. easily structure data from patient intake and send to an EHR. We pull data out of the tools they use to deliver care and run the business, unify and normalize the data, and then send it to the tools that need it. | San Francisco | CA | 2 - 10 | 2022 | $3,500,000 |
A health benefits company that reduces employer spend and improves employee experience. | Pittsburgh | PA | 10 - 50 | 2022 | $4,620,000 |
We are a design, technology, and entrepreneurship organization at UCLA focused on solving pressing problems on our campus. We aim to turn the the theory we learn in the classroom into real software products that benefit the UCLA Bruin community. We work in small teams, build fast, and produce excellent results.
Built by Students, For Students. #MoonshotsForUCLA
Founded in April 2017 by Akhil Nadendla. | Los Angeles | CA | 20 - 50 | 2022 | |
RevOpsis Therapeutics has directed its efforts towards addressing vision loss. By utilizing their exclusive bispecific Surrobody platform, the company aims to target a diverse range of ocular conditions with potential therapeutic agents. The company was founded in 2022 and is based in Springfield, Illinois, United States. | | IL | 5 - 10 | 2022 | $26,195,004 |
CorriXR Therapeutics is a biotechnology company. The company is headquartered in Wilmington, Delaware, United States. | Wilmington | DE | 5 - 10 | 2022 | $7,525,179 |
Enumera Molecular is a life science tools company developing rapid, low cost solutions for the of assessment of biomolecules via liquid biopsy. | Ann Arbor | MI | 20 - 50 | 2022 | $12,500,000 |
Developing the next generation of oncology therapies for patients. | | | 20 - 100 | 2022 | $841,850,004 |
We believe all seniors regardless of means deserve concierge primary care & wellness, without the concierge fees. They've earned it. Sage Health builds enriching neighborhood health centers that are easy to access, provide or arrange for all of our patients' healthcare needs, and partner with Medicare Advantage plans that fully cover primary care. Unlike other physician practices, a Sage Health physician has a patient panel of 400 or less, and we collaborate with the best outcomes-oriented specialists and hospitals in each market. Because we are not a fee-for-service provider and manage patients within a global capitation budget provided by Medicare Advantage plans, our only concern and motivation is to keep our seniors healthy. Sage Health is a destination for the best risk provider talent in the country who are building the new standard-bearing senior model for the United States. | Encinitas | CA | 10 - 50 | 2022 | |
Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics. | Berkeley | CA | 5 - 20 | 2022 | $13,400,000 |
Piezo Therapeutics develops a uniquely engineered platform that uses electric pulses and microneedles to deliver therapeutics to the body. The company was founded in 2022 and is headquartered in Atlanta, Georgia, United States. | Atlanta | GA | 5 - 10 | 2022 | $2,000,000 |
Instrumentum is a healthcare company that offers medical device for surgical purposes. | Boca Raton | FL | 20 - 50 | 2022 | $7,115,000 |
Metsera operates as a clinical-stage biopharmaceutical company. | New York | NY | 50 - 100 | 2022 | $505,000,000 |
Bectas Therapeutics is a biotech company that develops monoclonal antibody therapies for cancer. | Houston | TX | 10 - 50 | 2022 | $5,550,000 |
KeyCare is a virtual care platform powered by Epic that was created to assist forward-thinking health systems in increasing patient access and quality by enhancing the alternatives available for virtual care. | Chicago | IL | 10 - 50 | 2022 | $54,400,000 |
Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness. Aethon's unique anti-drug-peptide conjugate/MHC antibodies are intended to be employed in conjunction with TCI of RAS, EGFR, and other cancer-associated mutations. | New York | NY | 5 - 20 | 2022 | $30,000,000 |
3Aware provides aiSurveillance for medical devices by offering access, analysis, and alerts of real-world clinical data. | Indianapolis | IN | 20 - 50 | 2022 | $3,643,156 |
Syntis Bio operates as a late-stage preclinical company intended to develop a new class of therapy. The company's drug uses novel formulations for oral therapies that target specific tissues, enabling users to increase bioavailability. | Milton | MA | 5 - 20 | 2022 | $53,372,180 |
Relief Cardiovascular, an inQB8 Medical Technologies portfolio company, is creating a novel smart implant to decongest heart failure patients | Costa Mesa | CA | 5 - 20 | 2022 | $12,000,000 |
Instalab is a healthcare company that provides medical testing, medication, and health consultations. | New York | NY | 10 - 50 | 2022 | $500,000 |
Keylika developed a platform synthesis technology for mixed ligand metal complexes that is used to generate a multitude of organometallic drugs for treating a wide range of therapeutic conditions: hematology, pain and inflammation, metabolic disorders to infectious diseases and oncology. | Walnut Creek | CA | 2 - 10 | 2022 | |
We are a one-stop-shop for cardiovascular health. Empower yourself with research-backed info on your heart condition and how to prevent progression. Connect with a certified healthcare professional via video chat, messaging, and goal-setting to stay accountable. Stay in control of your health journey with a single dashboard that combines key data and behavior tracking. Share with ease. | Austin | TX | 5 - 10 | 2022 | $4,980,000 |